Related Experiment Video
Updated: Feb 14, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Vector-Based Comparison and Average Slope Can Refine Bioequivalence Claims: A Machine and Deep Learning Approach.
Maria Kokkali1, Vangelis D Karalis1,2
1Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Two new methods, absorption rates (AS) and vector-based clinical endpoints (VBC), enhance bioequivalence studies. Combining AS and VBC improves accuracy, reduces variability, and lowers costs for drug development.
Area of Science:
- Pharmacokinetics and Biopharmaceutics
- Statistical Modeling in Clinical Trials
Background:
- Bioequivalence (BE) studies are crucial for drug development, ensuring therapeutic equivalence.
- Current BE study methods face challenges in accuracy, efficiency, and cost.
Purpose of the Study:
- To evaluate the combined advantages of Absorption Rate (AS) and Vector-Based Clinical endpoints (VBC) in bioequivalence studies.
- To assess the performance of AS and VBC against standard statistical methods and advanced machine learning techniques.
Main Methods:
- Utilized 14 real-world datasets to assess the performance of AS and VBC.
- Applied standard regulatory statistical methods alongside machine learning and artificial neural networks.
- Analyzed absorption rates using AS and clinical endpoints using VBC, breaking them into independent components.
Main Results:
- The combination of AS and VBC accurately measures absorption rates while significantly reducing data variability.
- This integrated approach enhances statistical power and effectively addresses multiplicity issues.
- The methods support the use of smaller sample sizes, leading to simplified study designs.
Conclusions:
- The joint application of AS and VBC offers a precise and efficient approach to defining absorption rates in BE studies.
- These innovative methods improve study outcomes, reduce resource requirements, and shorten completion times.
- AS and VBC represent valuable tools for modern bioequivalence analysis, optimizing drug development processes.
More Related Videos
09:34A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
Published on: September 25, 2021
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Average and Instantaneous Velocity Vectors
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Bioequivalence: Overview
Testing a Claim about Mean: Known Population SD
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
Average Acceleration
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...